Back
BioLine Rx Vs. Can Fite Biofarma Industry Stock Comparison
Sell
32
BLRX
BioLine Rx
Last Price:
0.28
Seasonality Move:
5.57%
Sell
42
CANF
Can Fite Biofarma
Last Price:
1.96
Seasonality Move:
-6.94%
Sell
32
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.28. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $1.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
BLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 29.69 | Sell |
| Chaikin Money Flow: | -2669932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.49) | Sell |
| Bollinger Bands (100): | (0.46 - 0.74) | Sell |
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 35.7 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.96 - 2.5) | Sell |
| Bollinger Bands (100): | (1.98 - 3.06) | Sell |
BLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.44 | Sell |
| 20-day SMA: | 0.44 | Sell |
| 50-day SMA: | 0.49 | Sell |
| 200-day SMA: | 0.73 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 0.49 | Sell |
| 200-day EMA: | 0.74 | Sell |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 2.21 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 2.01 | Sell |
| 20-day EMA: | 2.11 | Sell |
| 50-day EMA: | 2.24 | Sell |
| 200-day EMA: | 2.45 | Sell |
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.
BioLine Rx Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Can Fite Biofarma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||